CA963000A - 15.alpha.,16.alpha.-METHYLENE-STEROIDS - Google Patents

15.alpha.,16.alpha.-METHYLENE-STEROIDS

Info

Publication number
CA963000A
CA963000A CA135,480A CA135480A CA963000A CA 963000 A CA963000 A CA 963000A CA 135480 A CA135480 A CA 135480A CA 963000 A CA963000 A CA 963000A
Authority
CA
Canada
Prior art keywords
alpha
steroids
methylene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA135,480A
Other languages
English (en)
Other versions
CA135480S (en
Inventor
Rudolf Wiechert
Hermann Steinbeck
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Application granted granted Critical
Publication of CA963000A publication Critical patent/CA963000A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/0065—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by an OH group free esterified or etherified
    • C07J7/0075—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by an OH group free esterified or etherified substituted in position 17 alfa
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • C07J53/004—3 membered carbocyclic rings
    • C07J53/008—3 membered carbocyclic rings in position 15/16

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
CA135,480A 1971-02-24 1972-02-24 15.alpha.,16.alpha.-METHYLENE-STEROIDS Expired CA963000A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2109555A DE2109555C3 (de) 1971-02-24 1971-02-24 Neue 15 a , 16 a -Methylensteroide, diese enthaltende Arzneimittel sowie Verfahren zu ihrei Herstellung

Publications (1)

Publication Number Publication Date
CA963000A true CA963000A (en) 1975-02-18

Family

ID=5800118

Family Applications (1)

Application Number Title Priority Date Filing Date
CA135,480A Expired CA963000A (en) 1971-02-24 1972-02-24 15.alpha.,16.alpha.-METHYLENE-STEROIDS

Country Status (21)

Country Link
US (1) US3749742A (sv)
AT (2) AT315393B (sv)
AU (1) AU456892B2 (sv)
BE (1) BE779797A (sv)
CA (1) CA963000A (sv)
CH (1) CH581149A5 (sv)
CS (2) CS167345B2 (sv)
DD (1) DD96065A5 (sv)
DE (1) DE2109555C3 (sv)
DK (1) DK130987B (sv)
ES (1) ES400056A1 (sv)
FI (1) FI49029C (sv)
FR (1) FR2126334B1 (sv)
GB (1) GB1383334A (sv)
HU (1) HU162901B (sv)
IE (1) IE36121B1 (sv)
IL (1) IL38828A (sv)
NL (1) NL7202466A (sv)
NO (1) NO135527C (sv)
SE (1) SE377338B (sv)
ZA (1) ZA721052B (sv)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3994937A (en) * 1972-02-11 1976-11-30 Schering Aktiengesellschaft 15α,16α-Methylene-4-estren-17β-ols
DE2456068A1 (de) * 1974-11-23 1976-08-12 Schering Ag Verfahren zur herstellung von oestren3,17-dion-derivaten
DE102007027635A1 (de) 2007-06-12 2008-12-18 Bayer Schering Pharma Aktiengesellschaft 17ß-Cyano-19-androst-4-en-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel
BE1027859B1 (fr) * 2019-12-13 2021-07-14 Georges Debled Hormone stéroïde pour la prévention de maladies associées au vieillissement

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1643005C3 (de) * 1967-02-09 1975-05-22 Schering Ag, 1000 Berlin Und 4619 Bergkamen 15,16beta-Methylen-testosterone, Verfahren zu ihrer Herstellung sowie diese Steroide enthaltende Mittel

Also Published As

Publication number Publication date
HU162901B (sv) 1973-04-28
NL7202466A (sv) 1972-08-28
FR2126334B1 (sv) 1975-03-14
ES400056A1 (es) 1974-12-16
IL38828A0 (en) 1972-04-27
FI49029C (sv) 1975-03-10
DE2109555A1 (de) 1972-09-07
DE2109555B2 (de) 1980-03-06
DE2109555C3 (de) 1980-10-30
US3749742A (en) 1973-07-31
DD96065A5 (sv) 1973-03-05
IE36121B1 (en) 1976-08-18
DK130987C (sv) 1975-10-06
NO135527C (sv) 1977-04-20
FR2126334A1 (sv) 1972-10-06
BE779797A (fr) 1972-08-24
AU456892B2 (en) 1974-12-16
CS167346B2 (sv) 1976-04-29
AT315393B (de) 1974-05-27
AT323349B (de) 1975-07-10
CH581149A5 (sv) 1976-10-29
AU3923372A (en) 1973-08-23
ZA721052B (en) 1972-10-25
IE36121L (en) 1972-08-24
IL38828A (en) 1975-12-31
NO135527B (sv) 1977-01-10
SE377338B (sv) 1975-06-30
CS167345B2 (sv) 1976-04-29
GB1383334A (en) 1974-02-12
DK130987B (da) 1975-05-12
FI49029B (sv) 1974-12-02

Similar Documents

Publication Publication Date Title
CA962666A (en) 1,25-dihydroxycholecaliferol
CA988092A (en) 4,5-dihalopyrrole-2-carbonitriles
AU463873B2 (en) 1, 4-bis-ACYLPIPERAZINES
CA997763A (en) 2,4,diamino-5-benzylpyrimidine
AU468410B2 (en) 2, 4-diamino-5-benzyl-pyrimidines
CA963000A (en) 15.alpha.,16.alpha.-METHYLENE-STEROIDS
AU468447B2 (en) 2, 4-diamino-5-benzyl-pyrimidines
CA947277A (en) 6.alpha.-FLUORO-16.alpha.,18-DIMETHYL-.DELTA.1,4-PREGNADIENE-3-20-DIONES
CA975378A (en) 5-hydoxymethyl-(1,3-dioxa-2-silacyclohexanes)
CA976543A (en) 4,6,8(14)-triene-steroids
AU468307B2 (en) 1, 2-biguanides
CA868891A (en) 16.alpha.,17-ALKYLIDENDIOXY-18-METHYL-19-NOR-PROGESTERONES
CA883336A (en) 1,3,3-TRIMETHYL-BIS(.alpha.-T-BUTYLPEROXYISOPROPYL)-1-PHENYLINDANE
CA888179A (en) 16.alpha.-ALKYL-STEROIDS
CA865732A (en) 17.alpha.-HALOALKYNYL-OESTRADIOL
CA871762A (en) 2',5'-dihalo-3-tert.alkyl-5-nitrosalicylanilides
CA866779A (en) 9.beta.,10.alpha.-STEROID
CA882103A (en) 11.beta.-HYDROXY-5.alpha.,6.alpha.-EPOXYSTEROIDE
CA887639A (en) 2,3-EPITHIO-5.alpha.-ANDROST-6-ENE STEROIDS
CA865743A (en) 5,10-epoxy-dibenzocycloheptenes
CA871120A (en) 3,4-dihydroquinazolinones
CA871704A (en) 2,6-methano-3-benzazocines
CA872219A (en) 16,17-alkylidenediazopregnanes
CA874978A (en) 3,4-dihydroquinazolinones
CA874979A (en) 3,4-dihydroquinazolinones